Integrated Wealth Concepts LLC Purchases 709 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Integrated Wealth Concepts LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,530 shares of the medical equipment provider's stock after acquiring an additional 709 shares during the quarter. Integrated Wealth Concepts LLC's holdings in Intuitive Surgical were worth $2,886,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in ISRG. Bennett Selby Investments LP boosted its holdings in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after buying an additional 17 shares during the period. Onefund LLC increased its holdings in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after purchasing an additional 18 shares in the last quarter. LVW Advisors LLC increased its position in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. increased its stake in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after buying an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC raised its position in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock valued at $275,000 after acquiring an additional 19 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares of the company's stock, valued at $1,936,380. The trade was a 7.58 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Fredrik Widman sold 810 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now directly owns 473 shares of the company's stock, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 30,913 shares of company stock valued at $15,981,143. Insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Up 0.2 %

Shares of ISRG traded up $0.91 during trading hours on Wednesday, reaching $515.80. The stock had a trading volume of 1,650,105 shares, compared to its average volume of 1,617,599. Intuitive Surgical, Inc. has a 12 month low of $367.39 and a 12 month high of $616.00. The company has a market capitalization of $184.87 billion, a price-to-earnings ratio of 80.47, a P/E/G ratio of 5.85 and a beta of 1.55. The firm has a 50-day simple moving average of $508.20 and a 200 day simple moving average of $533.13.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the prior year, the firm posted $1.50 EPS. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Royal Bank of Canada cut their price objective on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. UBS Group increased their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Truist Financial lowered their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Finally, Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.